Patents by Inventor Philip E. Hansen

Philip E. Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azole-fused peptides and processes for preparation thereof
    Patent number: 5378803
    Abstract: Azole-fused peptides useful as Substance P antagonists and analgesics, for example ##STR1## wherein ##STR2## represents ##STR3## wherein X is O, S or NH and * is D, or as intermediates therefor are prepared by azole and peptide forming methods.
    Type: Grant
    Filed: July 10, 1992
    Date of Patent: January 3, 1995
    Assignee: Sterling Winthrop Inc.
    Inventors: Barry A. Morgan, Thomas D. Gordon, Philip E. Hansen, Jasbir Singh
  • Nasal formulation and intranasal administration therewith
    Patent number: 5179079
    Abstract: The systemic absorption after intranasal administration of certain drugs, in particular pharmacologically active polypeptides is enhanced in the presence of a phospholipid, such as a phosphatidylcholine (a lecithin), preferably admixed with a vegetable oil.
    Type: Grant
    Filed: November 27, 1991
    Date of Patent: January 12, 1993
    Assignee: Novo Nordisk A/S
    Inventors: Philip E. Hansen, Anders R. Sorensen
  • Stabilized insulin preparations and a process for preparation thereof
    Patent number: 4614730
    Abstract: Isulin solutions physically stabilized by presence of one or more phospholipids, preferably a lecithin. The phospholipid is present in concentration of 10-200 .mu.g/ml.
    Type: Grant
    Filed: July 31, 1984
    Date of Patent: September 30, 1986
    Assignee: Novo Industri A/S
    Inventors: Philip E. Hansen, Jens J. V. Brange, Svend Havelund
  • Hexapeptide amides
    Patent number: 4472305
    Abstract: N-Terminal L-prolyl or D-prolyl hexapeptide amides useful as Substance P agonists and/or antagonists and as analgesics and/or antihypertensives and a process for preparing them are disclosed.
    Type: Grant
    Filed: May 17, 1983
    Date of Patent: September 18, 1984
    Assignee: Sterling Drug Inc.
    Inventors: Philip E. Hansen, Barry A. Morgan